Showing results (81-90 of 267) with videos related to
Sort By:
Pageof 27
Clinical Pharmacology and Therapeutics|March 2, 2024
The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development StrategiesYue Han, Rong Jiang, Jinlian Li, et al.Plos One|June 21, 2016
Cloning and Expression of β-Defensin from Soiny Mullet (Liza haematocheila), with Insights of its Antibacterial MechanismZhitao Qi, Wei Xu, Fancui Meng, et al.Biomedical Chromatography : BMC|July 6, 2017
Determination of tigecycline in human plasma by LC-MS/MS and its application to population pharmacokinetics study in Chinese patients with hospital-acquired pneumoniaRong Shao, Xingang Li, Yangmin Hu, et al.Signal Transduction and Targeted Therapy|October 8, 2020
Overview of current targeted therapy in gallbladder cancerXiaoling Song, Yunping Hu, Yongsheng Li, et al.BMJ Open|January 6, 2026
Parental preferences for generic substitution policies for children in China: a discrete choice experimentTi Pu, Junming Tan, Wanting Xin, et al.Advances in Therapy|February 15, 2024
Application of Northern Goshawk Back-Propagation Artificial Neural Network in the Prediction of Monohydroxycarbazepine Concentration in Patients with EpilepsyYichao Xu, Rong Shao, Mingdong Yang, et al.Bioanalysis|August 22, 2015
Simultaneous determination of hyzetimibe and its main active metabolite in plasma by LC-MS/MS and its application in PK studyJinliang Chen, Honggang Lou, Bo Jiang, et al.Mycology|August 21, 2018
Genetic diversity analyses of <i>Lasiodiplodia theobromae</i> on <i>Morus alba</i> and <i>Agave sisalana</i> based on RAPD and ISSR molecular markersHong-Hui Xie, Ji-Guang Wei, Rong-Shao Huang, et al.International Journal of Nanomedicine|September 2, 2017
VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancerJinliang Chen, Xiaoyi Sun, Rong Shao, et al.Translational Cancer Research|May 25, 2026
Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023Zhiming Huang, Xuanzhuang Lu, Haoyang Wang, et al.Pageof 27